ELVElevance Health

$439.89+28% 1Y

$439.89

$277.8952 weeks$445.34

ELV in its own filings

Nothing in ELV's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.

566

Events found in the filings · across 2,629 filings · the record starts in 2001

Hard flags: none
Hard flags
Most recent filing: Oct 21, 2026
Most recent filing · Form 10-Q
Record starts: Nov 14, 2001
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Jan 27, 2027
Security removed from listing or deregistered5 occurrences · usually a matured note or preferred class, not the common shares: 2018-05-01
SEC comment-letter activity42 occurrences: 2015-10-23

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Mar 2, 2026Regulation FD Disclosure On February 27, 2026, Elevance Health, Inc. (the “Company”) was notified by the Centers for Medicare & Medicaid Services (“CMS”) of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company’s Medicare Advantage-Prescription Drug (“MA-PD”) …Other event · Form 8-K
Feb 26, 2026On February 26, 2026, Elevance Health, Inc. (the “Company”) announced certain management changes. Among these changes, Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, to devote more time to family commitments.Director or officer change · Form 8-K
Dec 10, 2025On December 10, 2025, the Board of Directors (the “Board”) of Elevance Health, Inc. (the “Company”) elected Amy W. Schulman to serve as an independent director effective January 12, 2026, with a term expiring at the Company’s 2028 annual meeting of shareholders.Director or officer change · Form 8-K